Clinical Trial Update: Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM) [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 trial evaluating the efficacy and safety of the fixed-dose combination vildagliptin/metformin in adults with Type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Galvus Met (vildagliptin/metformin)

Snippet

Sponsor: Novartis | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED